1. Home
  2. AQMS vs COCP Comparison

AQMS vs COCP Comparison

Compare AQMS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$2.76

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$1.02

Market Cap

14.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AQMS
COCP
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
14.1M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
AQMS
COCP
Price
$2.76
$1.02
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$6.00
AVG Volume (30 Days)
99.8K
68.1K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.65
EPS
N/A
N/A
Revenue
$2,100,000.00
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.86
52 Week High
$39.37
$2.19

Technical Indicators

Market Signals
Indicator
AQMS
COCP
Relative Strength Index (RSI) 32.46 41.86
Support Level $2.51 $0.99
Resistance Level $4.36 $1.11
Average True Range (ATR) 0.19 0.05
MACD 0.01 0.01
Stochastic Oscillator 5.33 50.00

Price Performance

Historical Comparison
AQMS
COCP

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: